The ROE as of December 2024 (TTM) for Vascular Biogenics Ltd. (VBLT) is -95.94%

According to Vascular Biogenics Ltd.’s latest financial reports and current stock price. The company's current ROE is -95.94%. This represents a change of 211.86% compared to the average of -30.76% of the last 4 quarters.

Vascular Biogenics Ltd. (VBLT) Historical ROE (quarterly & annually)

How has VBLT ROE performed in the past?

The mean historical ROE of Vascular Biogenics Ltd. over the last ten years is -30.55%. The current -95.94% ROE has changed 214.05% with respect to the historical average. Over the past ten years (40 quarters), VBLT's ROE was at its highest in in the June 2023 quarter at -4.54%. The ROE was at its lowest in in the June 2024 quarter at -72.63%.

Vascular Biogenics Ltd. (VBLT) ROE by Quarter and Year

Discovering the peaks and valleys of Vascular Biogenics Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Vascular Biogenics Ltd. (VBLT) Average ROE

How has VBLT ROE performed in the past?

The current ROE of Vascular Biogenics Ltd. (VBLT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Vascular Biogenics Ltd. (VBLT) ROE vs. Peers

How is VBLT’s ROE compared to its peers?

Vascular Biogenics Ltd.’s ROE is greater than Revelation Biosciences, Inc. (-311.33%), greater than Zura Bio Limited (-39.61%), greater than Phio Pharmaceuticals Corp. (-134.57%), greater than ZyVersa Therapeutics, Inc. (-25512.50%), greater than TransCode Therapeutics, Inc. (-649.01%), less than Panbela Therapeutics, Inc. (0%), less than Virax Biolabs Group Limited (304.71%), greater than Allarity Therapeutics, Inc. (-115.10%), greater than ContraFect Corporation (-328.22%), less than Avenue Therapeutics, Inc. (376.50%), greater than Acumen Pharmaceuticals, Inc. (-473.61%), greater than HOOKIPA Pharma Inc. (-32.99%), greater than Day One Biopharmaceuticals, Inc. (-49.25%), greater than Inozyme Pharma, Inc. (-22.40%), greater than Terns Pharmaceuticals, Inc. (-88.42%), greater than X4 Pharmaceuticals, Inc. (-32.76%), greater than Galera Therapeutics, Inc. (-32.51%), less than null (14.34%),

Build a custom stock screener for Vascular Biogenics Ltd. (VBLT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vascular Biogenics Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vascular Biogenics Ltd. (VBLT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vascular Biogenics Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.